4
Changes in Ownership
Vera Therapeutics, Inc. Filed Acc 0001415889-24-013504
SVP, FINANCE, CHIEF ACCT OFFCR sold 30,837 shares at an average $42.30 ($1,304,435)
- SVP, FINANCE, CHIEF ACCT OFFCR acquired 28,872 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Young Joseph R · SVP, FINANCE, CHIEF ACCT OFFCR
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-05-15 | Exercise or conversion : show line 1 in the form | +8,221 | $3.94 | $32,387 | 61,392 | D |
| 2024-05-15 | Sale : show line 2 in the form | −8,221 | $42.17 | $346,680 | 53,171 | D |
| 2024-05-15 | Sale : show line 3 in the form | −1,965 | $42.68 | $83,866 | 51,206 | D |
| 2024-05-16 | Exercise or conversion : show line 4 in the form | +18,151 | $7.87 | $142,848 | 69,357 | D |
| 2024-05-16 | Sale : show line 5 in the form | −18,151 | $42.22 | $766,317 | 51,206 | D |
| 2024-05-16 | Exercise or conversion : show line 6 in the form | +2,500 | $7.87 | $19,675 | 53,706 | D |
| 2024-05-16 | Sale : show line 7 in the form | −2,500 | $43.03 | $107,573 | 51,206 | D |
| Open-market sales · 30,837 sh · avg $42.30 · $1,304,435 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-05-15 | Exercise or conversion : show line 8 in the form Stock Option (right to buy) | −8,221 | 58,589 | D |
| 2024-05-16 | Exercise or conversion : show line 9 in the form Stock Option (right to buy) | −20,651 | 69,349 | D |
Loading xslF345X05/form4-05172024_080555.xml…